Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme.

Pathology, research and practice - 1 Aug 2015

Liu Bin, Pang Bo, Liu Huajie, Arakawa Yoshiki, Zhang Rui, Feng Bin, Zhong Peng, Murata Daiki, Fan Haitao, Xin Tao, Zhao Guangyu, Liu Wei, Guo Hua, Luan Liming, Xu Shangchen, Miyamoto Susumu, Pang Qi

Abstract excerpt

The aim of this study was to explore the difference in high mobility group A1 (HMGA1) expression and isocitrate dehydrogenase (IDH) 1 R132H point mutation in initial and recurrent glioblastoma multiforme (GBM), and to further identify whether the expression of HMGA1 has a role in the malignant pr...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Brain Neoplasms
Share to Disease-Free Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Disease Progression

Share to Glioblastoma

Share to Isocitrate Dehydrogenase

Share to Mutation

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 26092597
DOI: 10.1016/j.prp.2015.05.004

Genes

HMGA1

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26092597-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High mobility group A1 expression shows negative correlation with recurrence time in patients with glioblastoma multiforme.PMID 26092597Read ↗

Survival in patients with glioblastoma at a first progression does not correlate with isocitrate dehydrogenase (IDH)1 gene mutation status.Semantic proximity Read ↗

Pathological spectrum in recurrences of glioblastoma multiforme.Semantic proximity Read ↗

Reduction of MLH1 and PMS2 confers temozolomide resistance and is associated with recurrence of glioblastomaSemantic proximity Read ↗

The expression of B7-H3 isoforms in newly diagnosed glioblastoma and recurrence and their functional roleSemantic proximity Read ↗

Atypical behavior of recurrent glioblastoma tumor cells with a highly adherent radial glial phenotype.Semantic proximity Read ↗

Early growth response 1 promoted the invasion of glioblastoma multiforme by elevating HMGB1.Semantic proximity Read ↗

Dynamic expression of 11 miRNAs in 83 consecutive primary and corresponding recurrent glioblastoma: correlation to treatment, time to recurrence, overall survival and MGMT methylation statusSemantic proximity Read ↗

[Analyses of IDH1 mutation and MGMT promoter methylation status for 5 cases of long-term survivors with glioblastoma].Semantic proximity Read ↗

Prognostic impact of molecular phenotype in patients with recurrent anaplastic glioma treated with prolonged administration of temozolomide.Semantic proximity Read ↗

Correlation between IDH1 gene mutation status and survival of patients treated for recurrent glioma.Semantic proximity Read ↗

Primary Astrocytic Tumours and Paired Recurrences have Similar Biological Features in IDH1, TP53 and TERTp Mutation and MGMT, ATRX Loss.Semantic proximity Read ↗

Promoter methylation and expression of <i>MGMT</i> and the DNA mismatch repair genes <i>MLH1, MSH2, MSH6</i> and <i>PMS2</i> in paired primary and recurrent glioblastomasSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.